[ad_1]
Merck & Co., Inc. (NYSE:MRK) Bernstein forty first Annual Strategic Selections Convention Might 29, 2025 3:30 PM ET
Company Individuals
Rob Davis – Chairman and Chief Govt Officer
Dean Li – Govt Vice President, President of Merck Analysis Labs
Convention Name Individuals
Courtney Breen – Bernstein
Courtney Breen
All proper. So, we’d kick off our dialog with Merck at present. My title is Courtney Breen. I’m the U.S. Biopharma Analyst right here at Bernstein. I’m very privileged to have Rob Davis and Dean Li from Merck right here with me at present. I am further privileged as a result of I used to get to work on the firm. And so, that is hopefully going to be an exquisite dialog and hopefully enlightening for plenty of buyers.
We’ll begin and let Rob set the tone, set a bit of little bit of this dialog up, after which we’ll spend a while diving by questions that I’ve ready.
Simply as a reminder, there may be the Pigeonhole app. Please do add questions into that, in order that we are able to combine them into the dialog at present and guarantee that all of your questions are answered and also you stroll away feeling such as you’ve obtained a extremely good understanding of the corporate.
So, with that, Rob, I am going to hand over to you and take us away.
Robert Davis
Nice. Effectively, one, thanks for having us and thanks for, everybody, who’s within the room and those that are listening on-line. Clearly, it is an attention-grabbing time proper now within the pharmaceutical trade and I am certain, we’ll have ample alternative to get into that. However what I might wish to give attention to for only a minute is, type of the journey we have been on at Merck, since I took over as CEO happening, simply virtually 4 years in the past, or CEO, did I say, CFO, did I get it?
[ad_2]